Safer, Evidence-Based Alternatives for Body Composition Goals Licensed options including semaglutide (Wegovy) and tirzepatide (Mounjaro), alongside structured nutrition and resistance training, provide evidence-based, MHRA-approved routes to body composition improvement for eligible adults
PlexusDx Precision Peptide Genetic Test identifies variations in the GLP1R gene (rs6923761) and MC4R pathway (rs17782313) that affect how your body responds to appetite-suppressing medications and metabolic stress
Exendin-4 Inhibits Growth and Augments Apoptosis of Ovarian Cancer Cells
These findings coincide with ongoing multidistrict litigation in the Eastern District of Pennsylvania, where more than 2,400 lawsuits allege that Ozempic, Mounjaro, and similar drugs cause severe gastrointestinal injuries
10.1007/978-1-4614-6093-0_15 123 SteligaA.KowiaskiP.CzubaE.WakowM.MoryJ.LietzauG
The structured dosing approach reduces side effects and supports consistent progress